BME PE Ratio & Valuation,Is BME Overvalued — Intellectia
BME Relative Valuation
BME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BME is overvalued; if below, it's undervalued.
Historical Valuation
Blackrock Health Sciences Trust(BME) is now in theFairzone, suggesting that its currentforward PSratio of0.00is consideredFairlycompared with the five-year average of0.00.The fair price ofBlackrock Health Sciences Trust(BME)is between--to--according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：40.72
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Blackrock Health Sciences Trust. (BME) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Blackrock Health Sciences Trust. (BME) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Blackrock Health Sciences Trust. (BME) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Blackrock Health Sciences Trust. (BME) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Blackrock Health Sciences Trust. (BME) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Blackrock Health Sciences Trust (BME) has a current Price-to-Book (P/B) ratio of 0.85. Compared to its 3-year average P/B ratio of 0.92 , the current P/B ratio is approximately -7.94% higher. Relative to its 5-year average P/B ratio of 0.92, the current P/B ratio is about -7.94% higher. Blackrock Health Sciences Trust (BME) has a Forward Free Cash Flow (FCF) yield of approximately 6.73%. Compared to its 3-year average FCF yield of 6.21%, the current FCF yield is approximately 8.39% lower. Relative to its 5-year average FCF yield of 6.21% , the current FCF yield is about 8.39% lower.
0.85
P/B
Median3y
0.92
Median5y
0.92
6.73
FCF Yield
Median3y
6.21
Median5y
6.21
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BME increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BME in the past 1 year is driven by Unknown.
Is Blackrock Health Sciences Trust (BME) currently overvalued or undervalued?
Blackrock Health Sciences Trust(BME)is now in theFairzone, suggesting that its currentforward PSratio of 0.00is consideredFairlycompared with the five-year average of0.00.The fair price of Blackrock Health Sciences Trust(BME)is betweentoaccording to relative valuation methord.
What is Blackrock Health Sciences Trust (BME) fair value?
BME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Blackrock Health Sciences Trust (BME) is between to according to relative valuation methord.
How does BME's valuation metrics compare to the industry average?
The average P/S ratio for BME's competitors is , providing a benchmark for relative valuation. Blackrock Health Sciences Trust Corp (BME) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Blackrock Health Sciences Trust (BME) as of Dec 19 2025?
As of Dec 19 2025, Blackrock Health Sciences Trust (BME) has a P/B ratio of 0.85. This indicates that the market values BME at 0.85 times its book value.
What is the current FCF Yield for Blackrock Health Sciences Trust (BME) as of Dec 19 2025?
As of Dec 19 2025, Blackrock Health Sciences Trust (BME) has a FCF Yield of 6.73%. This means that for every dollar of Blackrock Health Sciences Trust’s market capitalization, the company generates 6.73 cents in free cash flow.
What is the current Forward P/E ratio for Blackrock Health Sciences Trust (BME) as of Dec 19 2025?
As of Dec 19 2025, Blackrock Health Sciences Trust (BME) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Blackrock Health Sciences Trust’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Blackrock Health Sciences Trust (BME) as of Dec 19 2025?
As of Dec 19 2025, Blackrock Health Sciences Trust (BME) has a Forward P/S ratio of 0.00. This means the market is valuing BME at $0.00 for every dollar of expected revenue over the next 12 months.
